Ticker >

Chemcrux Enterprises share price

Chemcrux Enterprises Ltd.

BSE: 540395 SECTOR: Chemicals  57k   302   24

216.45
+0.10 (0.05%)
BSE: Today, 09:34 AM

Price Summary

Today's High

₹ 223

Today's Low

₹ 216

52 Week High

₹ 326

52 Week Low

₹ 192.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

320.54 Cr.

Enterprise Value

340.9 Cr.

No. of Shares

1.48 Cr.

P/E

43.58

P/B

4.36

Face Value

₹ 10

Div. Yield

0.46 %

Book Value (TTM)

₹  49.63

CASH

5.18 Cr.

DEBT

25.55 Cr.

Promoter Holding

72.92 %

EPS (TTM)

₹  4.97

Sales Growth

-17.54%

ROE

12.18 %

ROCE

13.81%

Profit Growth

-41.19 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-17.54%
3 Year13.74%
5 Year7.26%

Profit Growth

1 Year-41.19%
3 Year-1.86%
5 Year-1.94%

ROE%

1 Year12.18%
3 Year22.33%
5 Year25.84%

ROCE %

1 Year13.81%
3 Year27.01%
5 Year32.1%

Debt/Equity

0.3535

Price to Cash Flow

19.38

Interest Cover Ratio

14.7332

CFO/PAT (5 Yr. Avg.)

1.0659055284787

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2024 72.92 0
Mar 2024 72.92 0
Dec 2023 72.92 0
Sep 2023 72.92 0
Jun 2023 72.94 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 22.3335676945525% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.0119072807823% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 14.7332.
  • The Company has been maintaining an effective average operating margins of 22.0592712503772% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 29.9668 days.
  • Company has a healthy liquidity position with current ratio of 3.8822.
  • The company has a good cash flow management; CFO/PAT stands at 1.0659055284787.
  • The company has a high promoter holding of 72.92%.

 Limitations

  • The company has shown a poor profit growth of -1.86007607907291% for the Past 3 years.
  • The company has shown a poor revenue growth of 13.7362081299582% for the Past 3 years.
  • The company is trading at a high PE of 43.58.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 22.29 15.84 21.81 18.54 17.11
Total Expenditure 18.42 13.5 17.43 15.91 15.04
Operating Profit 3.86 2.34 4.38 2.63 2.07
Other Income 0.18 0.24 0.56 0.35 0.39
Interest 0.31 0.22 0.17 0.13 0.13
Depreciation 0.57 0.58 0.58 0.55 0.56
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.16 1.78 4.19 2.29 1.76
Tax 0.84 0.54 1.53 0.08 0.52
Profit After Tax 2.33 1.24 2.66 2.21 1.24
Adjusted EPS (Rs) 1.57 0.84 1.8 1.49 0.84

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 57.45 53.33 95.27 95.15 78.47
Total Expenditure 42.7 40.78 74.59 73.7 65.25
Operating Profit 14.75 12.55 20.68 21.45 13.21
Other Income 0.93 0.8 1.02 1.05 1.34
Interest 0.32 0.15 0.17 0.82 0.83
Depreciation 1.18 1.2 1.59 2.04 2.29
Exceptional Items 0 0.05 0 0 0
Profit Before Tax 14.18 12.05 19.95 19.65 11.43
Tax 3.54 3.11 5.09 5.29 2.99
Net Profit 10.64 8.93 14.86 14.36 8.44
Adjusted EPS (Rs.) 7.19 6.03 10.03 9.7 5.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.94 4.94 14.81 14.81 14.81
Total Reserves 27.48 35.92 39.87 51.6 57.45
Borrowings 1.05 0.47 0 10.26 21.53
Other N/C liabilities 0.99 1.1 2.29 2.71 3.13
Current liabilities 10.1 6.26 26.14 13.84 12.95
Total Liabilities 44.55 48.69 83.11 93.22 109.87
Assets
Net Block 15.4 19.37 23.65 32.43 32.41
Capital WIP 0 0.32 0 0.31 21.06
Intangible WIP 0 0 0 0 0
Investments 0.05 0.72 0.05 0.05 0.05
Loans & Advances 1.36 0.79 3.97 4.43 5.38
Other N/C Assets 0 0 0.68 0.79 0.68
Current Assets 27.73 27.49 54.77 55.2 50.29
Total Assets 44.55 48.69 83.11 93.22 109.87
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 14.18 12.05 19.95 19.65 11.43
Adjustment 1.33 1.37 1.72 2.84 3.29
Changes in Assets & Liabilities -0.79 -0.61 -7.44 -4.02 4.52
Tax Paid -3.63 -3 -5.09 -3.65 -2.69
Operating Cash Flow 10.9 9.62 9.14 14.82 16.54
Investing Cash Flow -7.62 -8.16 -2.81 -20.48 -25.85
Financing Cash Flow -3.56 -0.76 2.76 0.96 7.4
Net Cash Flow -0.29 0.69 9.08 -4.7 -1.91

Corporate Actions

Investors Details

PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
promoters 72.94 72.92 72.92 72.92 72.92
sanjay marathe 36.47 36.46 36.46 36.46 36.46
shah girishkumar c 36.47 36.46 36.46 36.46 36.46
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 27.06 27.08 27.08 27.08 27.08
namita bhandare 1.49 1.49 1.49 1.49 1.49
prasenjit kumar paul 1.48 1.48 1.48 1.48 1.48

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Chemcrux Enterprises - Quaterly Results30 Jul 2024, 2:46PM Chemcrux Enterprises - Quaterly Results30 Jul 2024, 2:46PM Chemcrux Enterprises - Quaterly Results30 Jul 2024, 2:46PM Chemcrux Enterprises informs about certificate4 Jul 2024, 5:28PM Chemcrux Enterprises informs about press release7 May 2024, 5:18PM Chemcrux Enterprises - Quaterly Results6 May 2024, 4:55PM Chemcrux Enterprises - Quaterly Results6 May 2024, 4:55PM Chemcrux Enterprises - Quaterly Results6 May 2024, 4:55PM Chemcrux Enterprises informs about board meeting29 Apr 2024, 3:41PM Chemcrux Enterprises - Quaterly Results13 Feb 2024, 1:34PM Chemcrux Enterprises - Quaterly Results13 Feb 2024, 1:34PM Chemcrux Enterprises - Quaterly Results13 Feb 2024, 1:34PM Chemcrux Enterprises informs about annual report18 Aug 2023, 5:02PM Chemcrux Enterprises - Quaterly Results4 Aug 2023, 6:25PM Chemcrux Enterprises - Quaterly Results4 Aug 2023, 6:25PM Chemcrux Enterprises informs about closure of trading window30 Jun 2023, 2:02PM Chemcrux Enterprises - Quaterly Results20 May 2023, 5:18PM Chemcrux Enterprises - Quaterly Results20 May 2023, 5:18PM Chemcrux Enterprises - Quaterly Results20 May 2023, 5:18PM Chemcrux Enterprises informs about disclosure27 Apr 2023, 4:22PM Chemcrux Enterprises informs about closure of trading window31 Mar 2023, 4:36PM Chemcrux Enterprises - Quaterly Results13 Feb 2023, 2:34PM Chemcrux Enterprises - Quaterly Results13 Feb 2023, 2:34PM Chemcrux Enterprises - Quaterly Results13 Feb 2023, 2:34PM Chemcrux Enterprises - Quaterly Results12 Nov 2022, 2:38PM Chemcrux Enterprises - Quaterly Results12 Nov 2022, 2:38PM Chemcrux Enterprises informs about outcome of AGM24 Sep 2022, 3:36PM Chemcrux Enterprises informs about non-applicability of large corporate entity18 Apr 2022, 5:01PM Chemcrux Enterprises executes JV agreement with Kalintis Healthcare22 Dec 2021, 3:28PM Chemcrux Enterprises to acquire 50% stake in Kalichem8 Sep 2021, 3:58PM Chemcrux Enterprises informs about outcome of board meeting11 Jun 2021, 4:37PM Chemcrux Enterprises informs about non-applicability of large corporate entity23 Apr 2021, 4:10PM Chemcrux Enterprises informs about shutdown of production operations at ankleshwar plant19 Jan 2021, 3:26PM Chemcrux Enterprises shuts down production activities at Ankleshwar Plant19 Jan 2021, 2:42PM Chemcrux Enterprises shuts down production activities at Ankleshwar Plant 3 Sep 2020, 10:42AM Chemcrux Enterprises informs about newspaper publication20 Jul 2020, 3:32PM Chemcrux Enterprises informs about press release24 Apr 2020, 4:06PM

Chemcrux Enterprises Stock Price Analysis and Quick Research Report. Is Chemcrux Enterprises an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Chemcrux Enterprises stock price today is Rs 226. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Chemcrux Enterprises . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Chemcrux Enterprises has a PE ratio of 45.5039664961946 which is high and comparatively overvalued .

  • Share Price: - The current share price of Chemcrux Enterprises is Rs 226. One can use valuation calculators of ticker to know if Chemcrux Enterprises share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Chemcrux Enterprises has ROA of 8.316 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Chemcrux Enterprises has a Current ratio of 3.8822 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Chemcrux Enterprises has a ROE of 12.1795 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Chemcrux Enterprises has a Debt to Equity ratio of 0.3535 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Chemcrux Enterprises has reported revenue growth of -17.5372 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Chemcrux Enterprises for the current financial year is 16.8401828579002 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Chemcrux Enterprises is Rs 1 and the yield is 0.4425 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Chemcrux Enterprises is Rs 4.9666 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Chemcrux Enterprises in Ticker for free. Also, one can get the intrinsic value of Chemcrux Enterprises by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Chemcrux Enterprises
X